Brigas et al. (2021) described a pathogenic role of IL-17 in enhancing synaptic and cognitive dysfunction during the onset of AD and provided evidence that IL-17 can have a dual role that depends on its concentration, with the high levels leading to severe inflammation. The gene discussed is IL17A; the disease is Alzheimer disease.